Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 01, 2020 |
vetoed memo.292 |
Dec 20, 2019 |
delivered to governor |
Jun 20, 2019 |
returned to senate passed assembly |
Jun 19, 2019 |
ordered to third reading rules cal.456 substituted for a7246b |
Jun 17, 2019 |
referred to ways and means returned to assembly repassed senate |
Jun 14, 2019 |
amended on third reading 5935a |
Jun 14, 2019 |
vote reconsidered - restored to third reading returned to senate recalled from assembly |
Jun 12, 2019 |
referred to ways and means delivered to assembly passed senate |
Jun 04, 2019 |
ordered to third reading cal.1170 committee discharged and committed to rules |
May 16, 2019 |
referred to health |
Senate Bill S5935
Vetoed By Governor2019-2020 Legislative Session
Sponsored By
(D, WF) 40th Senate District
Archive: Last Bill Status - Vetoed by Governor
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Vetoed By Governor
- Signed By Governor
Actions
Votes
Bill Amendments
co-Sponsors
(D, WF) Senate District
(D) Senate District
(D, IP, WF) Senate District
2019-S5935 - Details
- Law Section:
- Social Services Law
- Laws Affected:
- Amd §§365-a & 364-j, Soc Serv L; amd §273, Pub Health L
2019-S5935 - Sponsor Memo
BILL NUMBER: S5935 SPONSOR: HARCKHAM TITLE OF BILL: An act to amend the social services law and the public health law, in relation to medication for the treatment of substance use disorders PURPOSE: This legislation will expand access to medications that treat substance use disorders. SUMMARY OF PROVISIONS: Section 1 amends subdivision 2 of section 365-a of the social services law by adding a new paragraph (gg) Section 2 amends subdivision 26-b of section 364-j of the social services law. Section 3 amends subdivision 10 of section 273 of the public health law. Section 4 sets the effective date.
2019-S5935 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 5935 2019-2020 Regular Sessions I N S E N A T E May 16, 2019 ___________ Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the social services law and the public health law, in relation to medication for the treatment of substance use disorders THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subdivision 2 of section 365-a of the social services law is amended by adding a new paragraph (gg) to read as follows: (GG) ALL UNITED STATES FOOD AND DRUG ADMINISTRATION APPROVED FORMS OF MEDICATION ASSISTED TREATMENT PRESCRIBED ACCORDING TO GENERALLY ACCEPTED NATIONAL PROFESSIONAL GUIDELINES FOR THE TREATMENT OF A SUBSTANCE USE DISORDER. SUCH MEDICATION ASSISTED TREATMENT SHALL NOT BE SUBJECT TO ANY PRIOR AUTHORIZATION MANDATE. § 2. Subdivision 26-b of section 364-j of the social services law, as added by section 4 of part B of chapter 69 of the laws of 2016, is amended to read as follows: 26-b. Managed care providers shall not require prior authorization for [an initial or renewal prescription for buprenorphine or injectable naltrexone for detoxification or maintenance treatment of opioid addiction unless the prescription is for a non-preferred or non-formu- lary form of the drug or as otherwise required by section 1927(k)(6) of the Social Security Act] ANY UNITED STATES FOOD AND DRUG ADMINISTRATION APPROVED FORMS OF MEDICATION ASSISTED TREATMENT PRESCRIBED ACCORDING TO GENERALLY ACCEPTED NATIONAL PROFESSIONAL GUIDELINES FOR THE TREATMENT OF A SUBSTANCE USE DISORDER. § 3. Subdivision 10 of section 273 of the public health law, as added by section 5 of part B of chapter 69 of the laws of 2016, is amended to read as follows: 10. Prior authorization shall not be required for [an initial or renewal prescription for buprenorphine or injectable naltrexone for detoxification or maintenance treatment of opioid addiction unless the EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
co-Sponsors
(D, WF) Senate District
(D) Senate District
(D, IP, WF) Senate District
(D, WF) Senate District
2019-S5935A (ACTIVE) - Details
- Law Section:
- Social Services Law
- Laws Affected:
- Amd §§365-a & 364-j, Soc Serv L; amd §273, Pub Health L
2019-S5935A (ACTIVE) - Sponsor Memo
BILL NUMBER: S5935A SPONSOR: HARCKHAM TITLE OF BILL: An act to amend the social services law and the public health law, in relation to medication for the treatment of substance use disorders PURPOSE: This legislation will expand access to medications that treat substance use disorders. SUMMARY OF SPECIFIC PROVISIONS: Section one amends subdivision 2 of section 365-a of the social services law by adding a new paragraph (gg) Section two amends subdivision 26-b of section 364-j of the social services law. Section three amends subdivision 10 of section 273 of the public health
2019-S5935A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 5935--A Cal. No. 1170 2019-2020 Regular Sessions I N S E N A T E May 16, 2019 ___________ Introduced by Sens. HARCKHAM, BIAGGI, CARLUCCI, KAPLAN -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- committee discharged and said bill committed to the Commit- tee on Rules -- reported favorably from said committee, ordered to a third reading, passed by Senate and delivered to the Assembly, recalled, vote reconsidered, restored to third reading, amended and ordered reprinted, retaining its place in the order of third reading AN ACT to amend the social services law and the public health law, in relation to medication for the treatment of substance use disorders THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subdivision 2 of section 365-a of the social services law is amended by adding a new paragraph (gg) to read as follows: (GG) ALL BUPRENORPHINE PRODUCTS, METHADONE OR LONG ACTING INJECTABLE NALTREXONE FOR DETOXIFICATION OR MAINTENANCE TREATMENT OF A SUBSTANCE USE DISORDER PRESCRIBED ACCORDING TO GENERALLY ACCEPTED NATIONAL PROFES- SIONAL GUIDELINES FOR THE TREATMENT OF A SUBSTANCE USE DISORDER. SUCH MEDICATION ASSISTED TREATMENT SHALL NOT BE SUBJECT TO ANY PRIOR AUTHORI- ZATION MANDATE. § 2. Subdivision 26-b of section 364-j of the social services law, as added by section 4 of part B of chapter 69 of the laws of 2016, is amended to read as follows: 26-b. Managed care providers shall not require prior authorization for [an initial or renewal prescription for buprenorphine or injectable naltrexone for detoxification or maintenance treatment of opioid addiction unless the prescription is for a non-preferred or non-formu- lary form of the drug or as otherwise required by section 1927(k)(6) of the Social Security Act] ANY BUPRENORPHINE PRODUCTS, METHADONE OR LONG ACTING INJECTABLE NALTREXONE FOR DETOXIFICATION OR MAINTENANCE TREATMENT OF A SUBSTANCE USE DISORDER PRESCRIBED ACCORDING TO GENERALLY ACCEPTED EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted.
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.